Michael K. Palmer - Concepedia

Author

Michael K. Palmer

The Christie Hospital

Also Known As

Michael K Palmer, Michael K. Palmer, Michael Palmer, Michael K. Palmer, michael K palmer, michael palmer

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The Christie Hospital AstraZeneca (United Kingdom)AstraZeneca (United States)Cancer Research UK Manchester Institute Johns Hopkins Medicine

About

Michael K. Palmer is an author at The Christie Hospital specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	402
2	Health Sciences	3	3	133
3	Public Health	1	1	48
4	Biochemistry	1	1	48
5	Biostatistics	1	1	48

Michael K. Palmer

Publications

698

Citations

H-Index

Page 1

	Year	Citations
Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003‐2004 to 2013‐2014) Michael K. Palmer, Peter P. Tóth Obesity	2019	159
Malignant melanoma in children and adolescents Charles B. Pratt, Michael K. Palmer, Nicholas Thatcher, Cancer Surgical OncologyTumoral PathologyPrimary LesionsMalignant DiseaseMedicine	1981	93
A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia A. David Marais, Frederick J. Raal, Evan A. Stein, Atherosclerosis Lipid DisorderHomozygous Familial HypercholesterolaemiaCardiovascular DiseaseMedicineComparative Study	2007	91
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) Michael Clearfield, John Amerena, Jean‐Pierre Bassand, Trials	2006	89
Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study Lawrence A. Leiter, Robert S. Rosenson, Evan A. Stein, Atherosclerosis Lipid DisorderPolaris StudyCardiovascular DiseaseMedicineVersus Atorvastatin 80	2007	60
The prognostic significance of radiological and symptomatic bone involvement in childhood acute lymphoblastic leukaemia Ian Hann, Subhash Gupta, Michael K. Palmer, Medical and Pediatric Oncology Full Skeletal SurveyPrognostic SignificanceOsteoporosisOrthopaedic SurgeryBone Disease	1979	50
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis Michael K. Palmer, Philip J. Barter, Pia Lundman, Clinical Biochemistry Lipid AnalysisVoyager AnalysisCardiometabolic RiskHyperlipidemiaLogistic Analysis	2018	48
Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy Mark Sculpher, Michael K. Palmer, Anne Heyes PharmacoEconomics Surgical OncologyHealth EconomicsColorectal SurgeryMedicineColorectal Cancer	2000	40
Prognostic significance of pretreatment serum β2-microglobulin levels in multiple myeloma J.H. Scarffe, Heather Anderson, Michael K. Palmer, European Journal of Cancer and Clinical Oncology Hematological MalignancyPrognostic BiomarkersMedicineHematologyPathology	1983	35
The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: A report from the Manchester Lymphoma Group Heather Anderson, Jeremy P. R. Jenkins, David J. Brigg, Clinical Radiology Lymphoid NeoplasiaManchester Lymphoma GroupMedicineSurgical PathologyPathology	1985	33

Page 1